UPC orders 17-country ban on EOFlow's pumps in Insulet feud

Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Medical company sees $452m trade secrets award cut by 87%

29 April 2025 US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.

Americas

‘A marathon and a sprint at the same time’: How we won $452m damages

12 December 2024 With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

Americas

EOFlow ordered to pay rival $452m over insulin patch trade secrets

5 December 2024 Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.

More features

IP agencies vital to pharma and biotech grind to a halt

USPTO trims workforce amid govt shutdown crisis

How impactful is the new USPTO director’s S101 decision?

Global vaccine patents rise, as data reveals shift in Big Pharma strategy

Philips wins unprecedented trade secret sanctions against Chinese defendants

Womble Bond Dickinson partners jump to rival firm

EPO ruling clarifies appeal rights, blocking third-party intervention

Biotech sues AstraZeneca and Cellectis over mRNA patents

UPC orders 17-country ban on EOFlow's pumps in Insulet feud

More on this story

Editor's picks

Editor's picks

More features